Intervention 1: Intervention group: Selenium tablet, 200 µg, daily, for 8 weeks orally. Intervention 2: Control group: Placebo tablet, daily, for 8 weeks orally.

2 trials

Sponsors

Kashan University of Medical Sciences, Arak University of Medical Sciences

Conditions

Coronary Heart Disease. Ischaemic heart disease (chronic) NOSPolycystic ovary syndrome. Sclerocystic ovary syndrome Stein-Leventhal syndrome

Phase 3

Effect of supplementation in treatment of Coronary Heart Disease

Active, not recruitingIRCT201407015623N22

Kashan University of Medical SciencesCoronary Heart Disease. Ischaemic heart disease (chronic) NOS

Start: 2014-07-07Target: 60Updated: 2019-11-05

Effect of supplementation in treatment of polycystic ovary syndrome

Active, not recruitingIRCT201408155623N25

Arak University of Medical SciencesPolycystic ovary syndrome. Sclerocystic ovary syndrome Stein-Leventhal syndrome

Start: 2014-08-12Target: 70Updated: 2019-11-05